Medcloud Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 03-01-2025
- Paid Up Capital ₹ 0.10 M
as on 03-01-2025
- Company Age 7 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2020)
- Profit -427.10%
(FY 2020)
- Ebitda -429.52%
(FY 2020)
- Net Worth -185.60%
(FY 2020)
- Total Assets -4.36%
(FY 2020)
About Medcloud Pharmaceuticals
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Swarn Tripathi and Uma Mishra serve as directors at the Company.
- CIN/LLPIN
U24304DL2017PTC317071
- Company No.
317071
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 May 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Medcloud Pharmaceuticals Private Limited offer?
Medcloud Pharmaceuticals Private Limited offers a wide range of products and services, including Common Disease Medicines, Cough Syrup.
Who are the key members and board of directors at Medcloud Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Swarn Tripathi  | Director | 02-May-2017 | Current |
| Uma Mishra | Director | 02-May-2017 | Current |
Financial Performance of Medcloud Pharmaceuticals.
Medcloud Pharmaceuticals Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 427.1% decrease in profit. The company's net worth observed a substantial decline by a decrease of 185.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medcloud Pharmaceuticals?
Unlock access to Medcloud Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medcloud Pharmaceuticals?
Unlock and access historical data on people associated with Medcloud Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medcloud Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medcloud Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
